|
2021
|
Invention
|
Oncolytic vaccinia virus cancer therapy.
Embodiments of the invention are directed methods that ... |
|
2019
|
Invention
|
Methods and compositions for production of vaccina virus. Certain embodiments are directed to vir... |
|
2018
|
Invention
|
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent ... |
|
2017
|
Invention
|
Methods and compositions for production of vaccinia virus. Certain embodiments are directed to vi... |
|
2015
|
Invention
|
Oncolytic vaccinia virus cancer therapy. 8 infectious viral particles of a TK-deficient, GM-CSF-e... |
|
|
Invention
|
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing... |
|
2014
|
P/S
|
Biopharmaceutical agents in the form of oncolytic viruses
for the prevention, diagnosis, and tre... |
|
|
P/S
|
Biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and trea... |
|
|
P/S
|
Providing information in the field of research on cancer and biologic pharmaceutical products for... |
|
|
Invention
|
Oncolytic vaccinia virus combination cancer therapy. Embodiments of the invention are directed me... |
|
2012
|
Invention
|
Methods and compositions concerning poxviruses and cancer. The present invention concerns methods... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
2011
|
P/S
|
Providing information in the field of cancer research and biologic pharmaceutical products for th... |
|
2008
|
Invention
|
Oncolytic vaccinia virus cancer therapy. Embodiments of the invention are directed methods that i... |
|
2003
|
Invention
|
Methods and compositions concerning poxviruses and cancer. The present invention concerns m... |
